PubMed:26582609
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 785-792 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T2 | 785-792 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T3 | 1066-1073 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T4 | 1066-1073 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T5 | 1100-1111 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
T6 | 1202-1209 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T7 | 1202-1209 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T8 | 1473-1480 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T9 | 1473-1480 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 785-792 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T3 | 1066-1073 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T5 | 1100-1111 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
T6 | 1202-1209 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T8 | 1473-1480 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 785-792 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T2 | 785-792 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T3 | 1066-1073 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T4 | 1066-1073 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T5 | 1100-1111 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
T6 | 1202-1209 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T7 | 1202-1209 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T8 | 1473-1480 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T9 | 1473-1480 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
TextSentencer_T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
TextSentencer_T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
TextSentencer_T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
TextSentencer_T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
TextSentencer_T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
TextSentencer_T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
TextSentencer_T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
TextSentencer_T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
TextSentencer_T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
TextSentencer_T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
TextSentencer_T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1075-1090 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
T2 | 1092-1094 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
T3 | 1100-1111 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
T4 | 1214-1216 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
T5 | 1484-1486 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 18-27 | FMAID:241982 | denotes | chemokine |
_T2 | 18-27 | FMAID:241983 | denotes | chemokine |
_T3 | 18-27 | FMAID:241981 | denotes | chemokine |
_T4 | 18-27 | FMAID:241980 | denotes | chemokine |
_T5 | 18-27 | FMAID:241985 | denotes | chemokine |
_T6 | 18-27 | FMAID:241984 | denotes | chemokine |
_T7 | 28-45 | FMAID:63011 | denotes | glycosaminoglycan |
_T8 | 28-45 | FMAID:167395 | denotes | glycosaminoglycan |
_T9 | 62-71 | FMAID:241981 | denotes | chemokine |
_T10 | 62-71 | FMAID:241980 | denotes | chemokine |
_T11 | 62-71 | FMAID:241983 | denotes | chemokine |
_T12 | 62-71 | FMAID:241982 | denotes | chemokine |
_T13 | 62-71 | FMAID:241985 | denotes | chemokine |
_T14 | 62-71 | FMAID:241984 | denotes | chemokine |
_T15 | 94-103 | FMAID:241985 | denotes | chemokine |
_T16 | 94-103 | FMAID:241982 | denotes | chemokine |
_T17 | 94-103 | FMAID:241983 | denotes | chemokine |
_T18 | 94-103 | FMAID:241981 | denotes | chemokine |
_T19 | 94-103 | FMAID:241980 | denotes | chemokine |
_T20 | 94-103 | FMAID:241984 | denotes | chemokine |
_T21 | 135-153 | FMAID:63011 | denotes | glycosaminoglycans |
_T22 | 135-153 | FMAID:167395 | denotes | glycosaminoglycans |
_T23 | 155-159 | FMAID:167404 | denotes | GAGs |
_T24 | 193-200 | FMAID:84785 | denotes | in cell |
_T25 | 193-200 | FMAID:199054 | denotes | in cell |
_T26 | 232-236 | FMAID:167404 | denotes | GAGs |
_T27 | 265-274 | FMAID:241985 | denotes | chemokine |
_T28 | 265-274 | FMAID:241984 | denotes | chemokine |
_T29 | 265-274 | FMAID:241983 | denotes | chemokine |
_T30 | 265-274 | FMAID:241981 | denotes | chemokine |
_T31 | 265-274 | FMAID:241982 | denotes | chemokine |
_T32 | 265-274 | FMAID:241980 | denotes | chemokine |
_T33 | 331-336 | FMAID:169002 | denotes | cells |
_T34 | 331-336 | FMAID:68646 | denotes | cells |
_T35 | 351-360 | FMAID:241982 | denotes | chemokine |
_T36 | 351-360 | FMAID:241983 | denotes | chemokine |
_T37 | 351-360 | FMAID:241980 | denotes | chemokine |
_T38 | 351-360 | FMAID:241985 | denotes | chemokine |
_T39 | 351-360 | FMAID:241984 | denotes | chemokine |
_T40 | 351-360 | FMAID:241981 | denotes | chemokine |
_T41 | 421-424 | FMAID:167404 | denotes | GAG |
_T42 | 476-483 | FMAID:50594 | denotes | surface |
_T43 | 476-483 | FMAID:146300 | denotes | surface |
_T44 | 539-548 | FMAID:241982 | denotes | chemokine |
_T45 | 539-548 | FMAID:241984 | denotes | chemokine |
_T46 | 539-548 | FMAID:241985 | denotes | chemokine |
_T47 | 539-548 | FMAID:241981 | denotes | chemokine |
_T48 | 539-548 | FMAID:241980 | denotes | chemokine |
_T49 | 539-548 | FMAID:241983 | denotes | chemokine |
_T50 | 568-571 | FMAID:167404 | denotes | GAG |
_T51 | 646-656 | FMAID:241982 | denotes | chemokines |
_T52 | 646-656 | FMAID:241983 | denotes | chemokines |
_T53 | 646-656 | FMAID:241985 | denotes | chemokines |
_T54 | 646-656 | FMAID:241981 | denotes | chemokines |
_T55 | 646-656 | FMAID:241980 | denotes | chemokines |
_T56 | 646-656 | FMAID:241984 | denotes | chemokines |
_T57 | 729-732 | FMAID:167404 | denotes | GAG |
_T58 | 785-792 | FMAID:167420 | denotes | heparin |
_T59 | 785-792 | FMAID:82839 | denotes | heparin |
_T60 | 846-856 | FMAID:241980 | denotes | chemokines |
_T61 | 846-856 | FMAID:241985 | denotes | chemokines |
_T62 | 846-856 | FMAID:241984 | denotes | chemokines |
_T63 | 846-856 | FMAID:241981 | denotes | chemokines |
_T64 | 846-856 | FMAID:241982 | denotes | chemokines |
_T65 | 846-856 | FMAID:241983 | denotes | chemokines |
_T66 | 997-1004 | FMAID:50594 | denotes | surface |
_T67 | 997-1004 | FMAID:146300 | denotes | surface |
_T68 | 1066-1073 | FMAID:167420 | denotes | heparin |
_T69 | 1066-1073 | FMAID:82839 | denotes | heparin |
_T70 | 1075-1082 | FMAID:67110 | denotes | heparan |
_T71 | 1075-1082 | FMAID:165191 | denotes | heparan |
_T72 | 1075-1090 | FMAID:167405 | denotes | heparan sulfate |
_T73 | 1075-1090 | FMAID:63023 | denotes | heparan sulfate |
_T74 | 1100-1119 | FMAID:196838 | denotes | chondroitin sulfate |
_T75 | 1100-1119 | FMAID:82837 | denotes | chondroitin sulfate |
_T76 | 1140-1150 | FMAID:241982 | denotes | chemokines |
_T77 | 1140-1150 | FMAID:241983 | denotes | chemokines |
_T78 | 1140-1150 | FMAID:241981 | denotes | chemokines |
_T79 | 1140-1150 | FMAID:241980 | denotes | chemokines |
_T80 | 1140-1150 | FMAID:241984 | denotes | chemokines |
_T81 | 1140-1150 | FMAID:241985 | denotes | chemokines |
_T82 | 1202-1209 | FMAID:82839 | denotes | heparin |
_T83 | 1202-1209 | FMAID:167420 | denotes | heparin |
_T84 | 1343-1348 | FMAID:68646 | denotes | cells |
_T85 | 1343-1348 | FMAID:169002 | denotes | cells |
_T86 | 1390-1397 | FMAID:199054 | denotes | in cell |
_T87 | 1390-1397 | FMAID:84785 | denotes | in cell |
_T88 | 1446-1455 | FMAID:241983 | denotes | chemokine |
_T89 | 1446-1455 | FMAID:241982 | denotes | chemokine |
_T90 | 1446-1455 | FMAID:241981 | denotes | chemokine |
_T91 | 1446-1455 | FMAID:241980 | denotes | chemokine |
_T92 | 1446-1455 | FMAID:241984 | denotes | chemokine |
_T93 | 1446-1455 | FMAID:241985 | denotes | chemokine |
_T94 | 1473-1480 | FMAID:167420 | denotes | heparin |
_T95 | 1473-1480 | FMAID:82839 | denotes | heparin |
_T96 | 1517-1527 | FMAID:241984 | denotes | chemokines |
_T97 | 1517-1527 | FMAID:241982 | denotes | chemokines |
_T98 | 1517-1527 | FMAID:241983 | denotes | chemokines |
_T99 | 1517-1527 | FMAID:241981 | denotes | chemokines |
_T100 | 1517-1527 | FMAID:241985 | denotes | chemokines |
_T101 | 1517-1527 | FMAID:241980 | denotes | chemokines |
_T102 | 1691-1700 | FMAID:241983 | denotes | chemokine |
_T103 | 1691-1700 | FMAID:241980 | denotes | chemokine |
_T104 | 1691-1700 | FMAID:241981 | denotes | chemokine |
_T105 | 1691-1700 | FMAID:241984 | denotes | chemokine |
_T106 | 1691-1700 | FMAID:241985 | denotes | chemokine |
_T107 | 1691-1700 | FMAID:241982 | denotes | chemokine |
_T108 | 1701-1704 | FMAID:167404 | denotes | GAG |
_T109 | 1791-1801 | FMAID:241982 | denotes | chemokines |
_T110 | 1791-1801 | FMAID:241983 | denotes | chemokines |
_T111 | 1791-1801 | FMAID:241981 | denotes | chemokines |
_T112 | 1791-1801 | FMAID:241985 | denotes | chemokines |
_T113 | 1791-1801 | FMAID:241980 | denotes | chemokines |
_T114 | 1791-1801 | FMAID:241984 | denotes | chemokines |
_T115 | 1806-1810 | FMAID:167404 | denotes | GAGs |
_T116 | 1845-1848 | FMAID:167404 | denotes | GAG |
_T117 | 1898-1907 | FMAID:241982 | denotes | chemokine |
_T118 | 1898-1907 | FMAID:241980 | denotes | chemokine |
_T119 | 1898-1907 | FMAID:241981 | denotes | chemokine |
_T120 | 1898-1907 | FMAID:241984 | denotes | chemokine |
_T121 | 1898-1907 | FMAID:241985 | denotes | chemokine |
_T122 | 1898-1907 | FMAID:241983 | denotes | chemokine |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 858-862 | http://www.uniprot.org/uniprot/P13500 | denotes | CCL2 |
T2 | 864-868 | http://www.uniprot.org/uniprot/P10147 | denotes | CCL3 |
T3 | 870-874 | http://www.uniprot.org/uniprot/P13501 | denotes | CCL5 |
T4 | 876-880 | http://www.uniprot.org/uniprot/P80098 | denotes | CCL7 |
T5 | 882-887 | http://www.uniprot.org/uniprot/P02776 | denotes | CXCL4 |
T6 | 889-894 | http://www.uniprot.org/uniprot/Q9UCR9 | denotes | CXCL8 |
T7 | 896-902 | http://www.uniprot.org/uniprot/O14625 | denotes | CXCL11 |
T8 | 907-913 | http://www.uniprot.org/uniprot/Q6ICW0 | denotes | CXCL12 |
T9 | 1123-1125 | http://www.uniprot.org/uniprot/O75390 | denotes | CS |
T10 | 1412-1414 | http://www.uniprot.org/uniprot/O75390 | denotes | CS |
T11 | 1550-1552 | http://www.uniprot.org/uniprot/O75390 | denotes | CS |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 72-87 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T2 | 72-87 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T3 | 104-119 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T4 | 104-119 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T5 | 331-336 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T6 | 361-376 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T7 | 361-376 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T8 | 549-564 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T9 | 549-564 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T10 | 832-845 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerizing |
T11 | 832-845 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerizing |
T12 | 926-941 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T13 | 926-941 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T14 | 1248-1263 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T15 | 1248-1263 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T16 | 1343-1348 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T17 | 1374-1389 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T18 | 1374-1389 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T19 | 1572-1587 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T20 | 1572-1587 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T21 | 1671-1686 | http://purl.bioontology.org/ontology/NCBITAXON/265229 | denotes | oligomerization |
T22 | 1671-1686 | http://purl.bioontology.org/ontology/NCBITAXON/441291 | denotes | oligomerization |
T23 | 1872-1881 | http://purl.bioontology.org/ontology/NCBITAXON/127244 | denotes | mechanism |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 252-261 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
T2 | 252-274 | http://purl.obolibrary.org/obo/GO_0042033 | denotes | formation of chemokine |
T3 | 321-336 | http://purl.obolibrary.org/obo/GO_0016477 | denotes | migrating cells |
T4 | 1083-1090 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
T5 | 1112-1119 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 124-131 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T2 | 468-475 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T3 | 572-579 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T4 | 1179-1186 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T5 | 1539-1546 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T6 | 124-131 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T7 | 468-475 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T8 | 572-579 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T9 | 1179-1186 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T10 | 1539-1546 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T11 | 124-131 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T12 | 468-475 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T13 | 572-579 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T14 | 1179-1186 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T15 | 1539-1546 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T16 | 124-131 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T17 | 468-475 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T18 | 572-579 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T19 | 1179-1186 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T20 | 1539-1546 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T21 | 124-153 | http://purl.obolibrary.org/obo/GO_0005539 | denotes | binding to glycosaminoglycans |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 196-200 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T2 | 331-336 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T3 | 1343-1348 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 458-467 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensive |
T2 | 593-604 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensively |
GlycoBiology-Motifs
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 785-792 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T2 | 1066-1073 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T3 | 1202-1209 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T4 | 1473-1480 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
T5 | 1100-1111 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | chondroitin |
T6 | 1100-1119 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | chondroitin sulfate |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 1100-1111 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
PD-GlycoEpitope-B_T2 | 1075-1090 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 458-467 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensive |
PD-UBERON-AE-B_T2 | 593-604 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensively |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 1123-1127 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
T2 | 1412-1416 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
T3 | 1550-1554 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1100-1111 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
T3 | 1075-1090 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T2 | 1092-1094 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T5 | 1214-1216 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T6 | 1484-1486 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 1123-1127 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
T2 | 1412-1416 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
T3 | 1550-1554 | Disease | denotes | CS-A | http://purl.obolibrary.org/obo/MONDO_0019569 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 1835-1839 | OrganismTaxon | denotes | idea | 76236 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
TextSentencer_T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
TextSentencer_T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
TextSentencer_T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
TextSentencer_T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
TextSentencer_T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
TextSentencer_T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
TextSentencer_T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
TextSentencer_T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
TextSentencer_T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
TextSentencer_T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
TextSentencer_T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-88 | Sentence | denotes | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. |
T2 | 89-213 | Sentence | denotes | Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. |
T3 | 214-337 | Sentence | denotes | Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. |
T4 | 338-511 | Sentence | denotes | In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. |
T5 | 512-616 | Sentence | denotes | However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. |
T6 | 617-793 | Sentence | denotes | Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. |
T7 | 794-1129 | Sentence | denotes | In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). |
T8 | 1130-1264 | Sentence | denotes | Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. |
T9 | 1265-1411 | Sentence | denotes | These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. |
T10 | 1412-1606 | Sentence | denotes | CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. |
T11 | 1607-1811 | Sentence | denotes | Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. |
T12 | 1812-1917 | Sentence | denotes | These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1100-1111 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
T3 | 1075-1090 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T2 | 1092-1094 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T5 | 1214-1216 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
T6 | 1484-1486 | Glycan | denotes | HS | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1075-1090 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T2 | 1092-1094 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T3 | 1100-1111 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
T4 | 1214-1216 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T5 | 1484-1486 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 1835-1839 | OrganismTaxon | denotes | idea | 76236 |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1075-1090 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T2 | 1092-1094 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T3 | 1100-1111 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
T4 | 1214-1216 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
T5 | 1484-1486 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |